The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome-Reference-Cited by-同舟云学术

The estrogen and c-Myc target gene HSPC111 is over-expressed in breast cancer and associated with poor patient outcome

Published:2008-03-29 Issue:2 Volume:10 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Butt Alison J,Sergio C Marcelo,Inman Claire K,Anderson Luke R,McNeil Catriona M,Russell Amanda J,Nousch Marco,Preiss Thomas,Biankin Andrew V,Sutherland Robert L,Musgrove Elizabeth A

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/bcr1985.pdf

Reference52 articles.

1. Colditz GA: Relationship between estrogen levels, use of hormone replacement therapy, and breast cancer. J Natl Cancer Inst. 1998, 90: 814-823.

2. Yager JD, Davidson NE: Estrogen carcinogenesis in breast cancer. N Engl J Med. 2006, 354: 270-282.

3. Sutherland RL, Hall RE, Taylor IW: Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. Cancer Res. 1983, 43: 3998-4006.

4. Taylor IW, Hodson PJ, Green MD, Sutherland RL: Effects of tamoxifen on cell cycle progression of synchronous MCF-7 human mammary carcinoma cells. Cancer Res. 1983, 43: 4007-4010.

5. Osborne CK, Boldt DH, Clark GM, Trent JM: Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase. Cancer Res. 1983, 43: 3583-3585.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. NOP16 promotes hepatocellular carcinoma progression and triggers EMT through the Keap1-Nrf2 signaling pathway;Technology and Health Care;2024-07-12

2. Investigation of shared molecular mechanisms underlying sepsis and heart failure via integrated analysis of multiple microarray data;2024-01-15

3. The multifaceted roles of small extracellular vesicles in metabolic reprogramming in the tumor microenvironments;PROTEOMICS;2024-01-03

4. A pan-cancer analysis of Dyskeratosis congenita 1 (DKC1) as a prognostic biomarker;Hereditas;2023-12-11

5. NOP16 is a histone mimetic that regulates Histone H3K27 methylation and gene repression;2023-06-13